Recent news on Prednisolone Sodium Phosphate

BioMarin Announces First Quarter 2007 Financial Results  -  Apr 30, 2007
PR Newswire (press release),...including Orapred(R) (prednisolone sodium phosphate oral solution) and Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets).

Orapred ODT Tastes Good  -  Mar 29, 2007
Drug Newswire (press release),Orapred ODT(TM) (Prednisolone sodium phosphate orally disintegrating tablets) is a prescription drug product indicated for the control of severe or

Orapred ODT Tastes Good  -  Mar 29, 2007
PR Newswire (press release),Important Safety Information Orapred ODT(TM) (Prednisolone sodium phosphate orally disintegrating tablets) is a prescription drug product indicated for the

BioMarin Announces Fourth Quarter and Full Year 2006 Financial Results  -  Feb 22, 2007
Drug Newswire (press release),...including Orapred(R) (prednisolone sodium phosphate oral solution) and Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets).

BioMarin Announces Third Quarter 2006 Financial Results  Nov 1, 2006
...million, respectively, and include royalties on net product sales of the Orapred product line, including Orapred(R) (prednisolone sodium phosphate oral solution ... -PR Newswire (press release), FDA Sends BioMarin Warning Letter Over OrapredCI Product Website  Oct 12, 2006
...which markets OrapredCI (prednisolone sodium phosphate oral solution) (Orapred) on behalf of BioMarin, that the Division of Drug Marketing, Advertising, and ... -PharmaLive.com (press release), BioMarin Announces US Launch of Orapred ODT Through Alliant ...  Aug 28, 2006
...(Nasdaq and SWX: BMRN - News News) today announced that Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets), the first FDA-approved ... -Yahoo! News

BioMarin Announces US Launch of Orapred ODT Through Alliant ...  Aug 28, 2006
...today announced that Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets), the first FDA-approved orally disintegrating tablet form of ... -PharmaLive.com

NutraCea to Present at Roth Capital Growth Conference and ...  Aug 29, 2006
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) recently announced that Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets), the first FDA ... -Financial News USA

Orapred ODT Arrives in US Market  Aug 28, 2006
Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets) is marketed in the United States by Alliant Pharmaceuticals, pursuant to a ... -Yahoo! News

NutraCea to Present at Roth Capital Growth Conference and ...  29 Aug 2006
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) recently announced that Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets), the first FDA ... -Financial News USA

BioMarin Announces US Launch of Orapred ODT Through Alliant ...  Aug 28, 2006
...(Nasdaq and SWX: BMRN - News News) today announced that Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets), the first FDA-approved ... -Yahoo! News

BioMarin Announces Second Quarter 2006 Financial Results  Aug 2, 2006
...milestone payment of $7.5 million from Alliant Pharmaceuticals, following FDA approval of Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating ... -Yahoo! News



Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 ...  May 11, 2006
Additionally, BioMarin has rights to receive payments and royalties related to Orapred(R) (prednisolone sodium phosphate oral solution). ... - Genetic Engineering News

BioMarin Announces First Quarter 2006 Financial Results  May 3, 2006
Net sales of Orapred(R) (prednisolone sodium phosphate oral solution), including the branded and authorized generic products, were $2.0 million for the first ... - PR Newswire

BioMarin to Present at the Rodman and Renshaw 3rd Annual Global ...  May 8, 2006
Additionally, BioMarin has rights to receive payments and royalties related to Orapred® (prednisolone sodium phosphate oral solution). ... - Yahoo! News





BioMarin and Alliant Pharmaceuticals Announce North American ...  Mar 15, 2006
...entered into a licensing and acquisition agreement pertaining to exclusive North American rights to the Orapred(R) (prednisolone sodium phosphate oral solution ... - PR Newswire

BioMarin Announces Closing of $295 Million Concurrent Public ...  Mar 30, 2006
Additionally, BioMarin has rights to receive payments and royalties related to Orapred(R) (prednisolone sodium phosphate oral solution). ... - PR Newswire

BioMarin and Serono Announce Positive Results From Phase 3 ...  Mar 15, 2006
...and commercialized by BioMarin, Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution ... - PR Newswire

BioMarin’s Shares Move On Phenoptin Phase III Success  Mar 16, 2006
...and a potential launch of Phenoptin, it made sense for BioMarin to license out North American rights to the Orapred (prednisolone sodium phosphate) product line ... - BioWorld Online (subscription)

BioMarin and Alliant in licensing deal  Mar 17, 2006
Orapred is the leading brand of liquid prednisolone sodium phosphate used to treat exacerbations of asthma and other inflammatory diseases and conditions in ... - Pharmaceutical Business Review

BioMarin and Serono Announce Positive Results From Phase 3 ...  Mar 15, 2006
...and commercialized by BioMarin, Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred® (prednisolone sodium phosphate oral solution) for ... - Yahoo! News



BioMarin to Present at Cowen & Co. 26th Annual Health Care ...  Feb 27, 2006
...and commercialized by BioMarin, Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred® (prednisolone sodium phosphate oral solution) for ... - Yahoo! News

BioMarin Receives Marketing Approval for Naglazyme in European ...  Jan 30, 2006
...and commercialized by BioMarin, Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution ... - MSN Money

BioMarin Receives FDA Fast Track Designation for Phenoptin for PKU  Jan 25, 2006
...and commercialized by BioMarin, Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred® (prednisolone sodium phosphate oral solution) for ... - Yahoo! News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional